Profits slump at AstraZeneca
April 24, 2014Sales and Marketing AZD9291, AstraZeneca, BMS, Brilinta, Q1
AstraZeneca has continued its poor run of form, with operating profit in the first quarter of 2014 falling 40% on …
PPD hires Bhooshi De Silva as senior VP


April 24, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing PPD, de silva
Contract research organisation Pharmaceutical Product Development (PPD) has added Bhooshi De Silva as senior VP of corporate development and strategy …
Sovaldi performs for Gilead
April 24, 2014Sales and Marketing Gilead, HCV, Q1, hepatitis C, sovaldi
Gilead Sciences’ once-daily, oral hepatitis C treatment Sovaldi has returned better than expected figures in the first quarter of the …
PrimeVigilance Receives Queen’s Award for Enterprise
April 23, 2014PrimeVigilance Limited (PrimeVigilance), the specialist pharmacovigilance service provider, has been honoured with the Queen’s Award for Enterprise 2014 in the …
Valeant makes $45.7 billion Allergan offer
April 23, 2014Sales and Marketing Allergan, Botox, GSK, Novartis, Pfizer, Valeant, merger, pershing
In the latest proposal in a flurry of merger and acquisition activity in the pharma sector, Valeant Pharmaceuticals International wants …
NICE rejects Kadcyla
April 23, 2014Sales and Marketing CDF, Cancer, Genentech, Kadcyla, NHS, NICE, Roche
NICE has delivered a severe blow to Roche by rejecting its breast cancer ‘smart bomb’ Kadcyla for NHS use in …
Merck Millipore confirms chief executive and president
April 23, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Merck Millipore, udit batra
Merck Millipore which is the life science division of Merck has named Dr Udit Batra as its incoming president and …
GSK and Novartis sign multi-billion dollar deal
April 23, 2014Research and Development, Sales and Marketing GSK, Novartis, Tafinlar, lilly, merger, tykerb, vaccines
GlaxoSmithKline and Novartis are radically shaking up their businesses, starting up a joint venture while selling off major parts of …
AstraZeneca ‘rejects Pfizer bid’
April 22, 2014Research and Development, Sales and Marketing AstraZeneca, Byetta, Onglyza, Pfizer, Soriot, merger
AstraZeneca has rebuffed a £60 billion bid from Pfizer, according to media reports. Both companies have declined to comment on …
GSK ‘to employ more doctors’
April 22, 2014Medical Communications, Sales and Marketing China, Poland, gsk. doctors, shannon
GlaxoSmithKline is to employ more doctors as members of staff in a bid to ensure that the company is seen …
Nanobiotix appoints head from Roche


April 22, 2014Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Roche, nanobiotix, otin
France-based clinical-stage nanomedicine firm Nanobiotix has hired Thierry Otin as its head of manufacturing and supply. Prior to joining Nanobiotix, …
Working Life: GE Healthcare’s Emmanuel Ligner
April 22, 2014Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GE Healthcare, Working Life, emmanuel linger
How did you find your way into your current role? There have been various circumstances in my professional career that …
Biologics lift for UK
April 22, 2014Manufacturing and Production, Sales and Marketing Cameron, UK, biologics, darlington, nbmc
Work has begun on a key new £38 million centre in Central Park, Darlington, which should increase the biologics capability …
arGEN-X appoints Evotec chief executive
April 14, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Evotec, arGEN-X, lanthaler
Belgium-based clinical stage human therapeutic antibody firm arGEN-X has appointed Dr Werner Lanthaler to its supervisory board.
 Lanthaler is currently …
Novartis ponders Horsham site future
April 14, 2014Research and Development, Sales and Marketing Horsham, Novartis, Osborne, PharmaVentures, medcity, research, site
Novartis has hired specialist consultancy firm PharmaVentures to help it decide how to re-use it former Horsham site. This comes …
GSK bribery controversy spreads to Poland
April 14, 2014Medical Communications, Sales and Marketing China, FDA, GSK, Witty, bribery, cctv, iraq
Poland has become the latest country in a string of bribery claims to hit GSK as it faces legal action …
How can ‘innovation’ be defined?
April 14, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, NHS, UK, eric low, innovation, myeloma
Innovation has been and continues to be an important topic of discussion for a number of different stakeholders and disciplines …
EMA to conduct major review into testosterone drugs
April 14, 2014Research and Development, Sales and Marketing EMA, EU, Europe, heart, testosterone
The European Medicines Agency has started a review of testosterone-containing medicines as concerns grow that they may increase the risk …
Latest content
ESTEVE CDMO adds $17.5m to Illinois expansion
Brenntag and dsm-firmenich expand biopharma vitamin partnership
